Abstract
Migraine has been hypothesized to be a syndrome of chronic low serotonin (5-HT) levels, but investigations of brain 5-HT levels have given equivocal results. Here, we used positron emission tomography (PET) imaging of the 5-HT(4) receptor as a proxy for brain 5-HT levels. Given that the 5-HT(4) receptor is inversely related to brain 5-HT levels, we hypothesized that between attacks migraine patients would have higher 5-HT(4) receptor binding compared to controls. Eighteen migraine patients without aura (migraine free >48 h), and 16 age- and sex-matched controls underwent PET scans after injection of [(11)C]SB207145, a specific 5-HT(4) receptor radioligand. An investigator blinded to group calculated a neocortical mean [(11)C]SB207145 binding potential (BP(ND)). Three migraine patients reported a migraine attack within 48 h after the scan and were excluded from the primary analysis. Comparing 15 migraine patients and 16 controls, we found that migraine patients have significantly lower neocortical 5-HT(4) receptor binding than controls (0.60 ± 0.09 vs. 0.67 ± 0.05, p = .024), corrected for 5-HTTLPR genotype, sex and age. We found no association between 5-HT(4) receptor binding and attack frequency, years with migraine or time since last migraine attack. Our finding of lower 5-HT(4) receptor binding in migraine patients is suggestive of higher brain 5-HT levels. This is in contrast with the current belief that migraine is associated with low brain 5-HT levels. High brain 5-HT levels may represent a trait of the migraine brain or it could be a consequence of migraine attacks.